Intuitive Surgical Inc (ISRG)
515.17
+7.62
(+1.50%)
USD |
NASDAQ |
Nov 05, 16:00
515.20
+0.03
(+0.01%)
After-Hours: 18:56
Intuitive Surgical Research and Development Expense (Annual): 998.80M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 998.80M |
| December 31, 2022 | 879.00M |
| December 31, 2021 | 671.00M |
| December 31, 2020 | 595.10M |
| December 31, 2019 | 557.30M |
| December 31, 2018 | 418.10M |
| December 31, 2017 | 328.60M |
| December 31, 2016 | 239.60M |
| December 31, 2015 | 197.40M |
| December 31, 2014 | 178.00M |
| December 31, 2013 | 167.70M |
| December 31, 2012 | 170.00M |
| December 31, 2011 | 140.20M |
| Date | Value |
|---|---|
| December 31, 2010 | 116.00M |
| December 31, 2009 | 95.10M |
| December 31, 2008 | 79.37M |
| December 31, 2007 | 48.86M |
| December 31, 2006 | 29.78M |
| December 31, 2005 | 17.35M |
| December 31, 2004 | 17.81M |
| December 31, 2003 | 16.19M |
| December 31, 2002 | 16.79M |
| December 31, 2001 | 13.85M |
| December 31, 2000 | 11.73M |
| December 31, 1999 | 11.13M |
| December 31, 1998 | 23.21M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
557.30M
Minimum
2019
998.80M
Maximum
2023
740.24M
Average
671.00M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Abbott Laboratories | 2.741B |
| Becton Dickinson & Co | 1.237B |
| Haemonetics Corp | 54.44M |
| Masimo Corp | 175.20M |
| Perspective Therapeutics Inc | 21.31M |